Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Psychedelic/Assisted Therapies Recent news which mentions Psychedelic/Assisted Therapies < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > NFL's Jon Feliciano Takes His Psychedelics Advocacy To The Field: Chooses MAPS As His "My Cleats, My Cause" December 05, 2023 Tags National Football League Sports News From Benzinga Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Tickers ATAI CMND CMPS CYBN Tags ATAI News GHRS From Benzinga Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company? December 04, 2023 Tickers BRAXF TRUFF Tags Psychedelics Benzinga Psychedelic/Assisted Therapies From Benzinga Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time' December 04, 2023 Tags Ketamine Treatment Chrissy Teigen Entertainment From Benzinga Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next? December 03, 2023 Tickers CYBN Tags News Penny Stocks Next/Generation Psychedelics From Benzinga Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains 'Confident' In Business Strategy November 29, 2023 Tickers TRUFF Tags News financial results TRUFF From Benzinga Seelos Therapeutics' $5.55M Public Offering As Stock Drop 35% November 29, 2023 Tickers IPOS SEEL Tags IPOs Psychedelic/Assisted Therapies Public Offering From Benzinga Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans November 27, 2023 Tickers DOD SEEL Tags DoD Markets SEEL From Benzinga Global Psychedelics: Norwegian User Trends & Finnish Interdisciplinary Conference November 26, 2023 Tags Markets Cannabis Market News From Benzinga Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment November 24, 2023 Tags Markets Cannabis Market News From Benzinga Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More November 24, 2023 Tickers ATAI AWKNF CMPS CYBN Tags ATAI News Penny Stocks From Benzinga Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice November 21, 2023 Tickers CMND Tags reverse stock split Markets CMND From Benzinga Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes November 20, 2023 Tags Cannabis Johns Hopkins University Market News From Benzinga UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center November 15, 2023 Tickers AWKNF CMPS Tags treatment/resistant depression Cannabis severe alcohol use disorder From Benzinga GH Research: Steady Expenses And $229M Cash Position For 2026 Runway November 14, 2023 Tickers GHRS Tags financial results News GHRS From Benzinga Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026 November 14, 2023 Tickers ATAI CMPS Tags Florian Brand Next/Generation Psychedelics Cannabis From Benzinga Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More November 12, 2023 Tickers ATAI CMPS CYBN DRUG Tags CYBN IXHL Psychedelic/Assisted Therapies From Benzinga Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? November 11, 2023 Tags Psychedelics Benzinga Veterans Day From Benzinga Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal November 10, 2023 Tickers CYBN Tags Markets CYBN Financing From Benzinga Worldwide Psychedelics Events: Miami, Croatia, D.C., France, UK, NY, Oregon, Arizona & SXSW November 09, 2023 Tags News Events Markets From Benzinga Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market November 08, 2023 Tickers PMBHF Tags Psychedelics Benzinga Psilocybin program From Benzinga Psychedelics Reform In California, Wisconsin, Illinois, Massachusetts & Pennsylvania November 05, 2023 Tags News controlled substances Government From Benzinga MindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved November 03, 2023 Tickers MNMD Tags Psychedelic/Assisted Therapies MDMA treatment Psychedelics From Benzinga Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find November 01, 2023 Tickers CYBN Tags Benzinga Psychedelics Psilocybin program From Benzinga Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio October 26, 2023 Tags Global Contracts Market News From Benzinga EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting October 26, 2023 Tags Regulations News Guidance From Benzinga Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics October 23, 2023 Tickers CYBN DMTTF Tags Markets M&A Market News From Benzinga Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted October 22, 2023 Tickers ATAI CMPS CYBN DMTTF Tags MNMD Benzinga HUGE From Benzinga Psychedelics Decriminalization In California: Eureka City Council Latest To Pass Resolution October 22, 2023 Tags Cannabis Market News Markets From Benzinga Orange Photonics: New High-Tech Testing For Psychedelic Products October 20, 2023 Tags Psychedelic/Assisted Therapies Psychedelics Benzinga From Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.